Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand

3

Oct 26 (Reuters) – Indian drugmaker Mankind Pharma reported an over 39% jump in second-quarter profit on Monday, helped by strong demand for chronic therapies such as diabetes and cardiac treatments,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)